Comparative Study of Iron Supplements in South Indian Antenatal Women with Iron Deficiency Anemia

Authors

  • R. Geetha Department of Pharmacology, Tagore Medical College and Hospital, Chennai, Tamil Nadu-600127, India.
  • S. Rageshwari Department of Pharmacology, Tagore Medical College and Hospital, Chennai, Tamil Nadu-600127, India.
  • S. Parvathavarthini Department of Pharmacology, Tagore Medical College and Hospital, Chennai, Tamil Nadu-600127, India.
  • K. R. Sowmia Department of Pharmacology, Tagore Medical College and Hospital, Chennai, Tamil Nadu-600127, India.
  • S. Priestly Vivekkumar Department of Pharmacology, Tagore Medical College and Hospital, Chennai, Tamil Nadu-600127, India.
  • Simhadri V. S. D. N. A. Nagesh Department of Pharmacology, Tagore Medical College and Hospital, Chennai, Tamil Nadu-600127, India.
  • A. Umamageswari Department of Pharmacology, Tagore Medical College and Hospital, Chennai, Tamil Nadu-600127, India.

DOI:

https://doi.org/10.17762/jaz.v44i4.2136

Keywords:

Antenatal women, carbonyl iron, iron deficiency anemia.

Abstract

BACKGROUND: Iron deficiency anemia is the most common nutritional disorder in the world. It is a major public health problem particularly among pregnant women with adverse effects on the mother and the new born. Iron supplementation is universally recommended to correct or prevent iron deficiency. AIMS & OBJECTIVE: The present study was conducted to compare the efficacy and tolerability of three oral iron preparations in anemic pregnant women of more than 14 weeks of gestation. MATERIALS AND METHODS: Randomized Control trial, done at Tagore Medical College and Hospital, Chennai. 60 antenatal women were selected; they were divided into three groups, 20 in each group. They were treated with Carbonyl iron, ferrous sulphate and ferrous fumarate. Hemoglobin estimation was done at 0 day, 30th and 60th day. Adverse effects were monitored. RESULTS: Data analysis showed an increase in haemoglobin levels in all three groups after the 30th day (p<0.05). Carbonyl iron showed highly significant increase (p<0.05) in the haemoglobin level as compared to the other two drugs at the end of the 60th day. CONCLUSION: Carbonyl iron is superior in efficacy when compared to ferrous sulphate and ferrous fumarate and is better tolerated. So carbonyl iron is safe in pregnancy and can be given as a supplement to treat iron deficiency anemia during pregnancy.

Downloads

Download data is not yet available.

Downloads

Published

2023-11-25

Issue

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.